Factors influencing the transition time from psoriasis to psoriatic arthritis: a real-world multicenter analysis.
📘
Journal:
Rheumatology international
📅
Published:
September 09, 2025
👥
Authors:
['Kılıç G', 'Kılıç E', 'Tekeoğlu İ', 'Sargın B', 'Cengiz G', 'Balta NC', 'Alkan H', 'Kasman SA', 'Şahin N', 'Orhan K', 'Gezer İA', 'Keskin D', 'Mülkoğlu C', 'Reşorlu H', 'Ataman Ş', 'Bal A', 'Duruöz MT', 'Kücükakkaş O', 'Şen N', 'Toprak M', 'Yurdakul OV', 'Melikoğlu MA', 'Ayhan FF', 'Baykul M', 'Bodur H', 'Çalış M', 'Çapkın E', 'Devrimsel G', 'Hizmetli S', 'Kamanlı A', 'Keskin Y', 'Ecesoy H', 'Kutluk Ö', 'Şendur ÖF', 'Tolu S', 'Tuncer T', 'Özgöçmen S', 'Nas K.']
🔬
Category:
Genetics
Uncover the factors behind the transition from psoriasis to psoriatic arthritis - from scalp psoriasis to family history, these insights can help identify high-risk patients and enable earlier intervention for better long-term outcomes.
This real-world, multicenter study examined the clinical and demographic predictors associated with the timing of transition from psoriasis (PsO) to psoriatic arthritis (PsA). Among 799 patients, 70.3% had a prolonged transition, with an average interval of 12.9 years. Factors like scalp/nail psoriasis, family history of PsO, and enthesitis were linked to a longer transition, while family history of PsA and older PsO onset age predicted a shorter transition. Recognizing these markers can support timely referral and intervention, minimizing diagnostic delay and improving long-term patient outcomes. Limitations include the observational design and potential regional differences in the study population.